gyki 53655 has been researched along with ubp 310 in 1 studies
Studies (gyki 53655) | Trials (gyki 53655) | Recent Studies (post-2010) (gyki 53655) | Studies (ubp 310) | Trials (ubp 310) | Recent Studies (post-2010) (ubp 310) |
---|---|---|---|---|---|
111 | 0 | 22 | 13 | 0 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jane, DE; Mulle, C; Perrais, D; Pinheiro, PS | 1 |
1 other study(ies) available for gyki 53655 and ubp 310
Article | Year |
---|---|
Antagonism of recombinant and native GluK3-containing kainate receptors.
Topics: Alanine; Animals; Animals, Newborn; Benzodiazepines; Biophysics; Cell Line, Transformed; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hippocampus; Humans; In Vitro Techniques; Kainic Acid; Membrane Potentials; Mice; Mice, Knockout; Mossy Fibers, Hippocampal; Neuronal Plasticity; Patch-Clamp Techniques; Protein Subunits; Pyramidal Cells; Receptors, Kainic Acid; Recombinant Proteins; Synaptic Transmission; Thymine; Transfection | 2009 |